Saltanat Zhazykbayeva
Bochum, NW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Prime-edited isogenic hiPSC-cardiomyocytes model short QT syndrome type 3 and drug responses.
Journal: Life sciences
Published: July 20, 2026
Phenotypes in Brugada syndrome with different genotypes triggered by fever or inflammation using gene-edited iPSCs.
Journal: Stem cell research & therapy
Published: May 08, 2025
Dysregulated inflammation, oxidative stress, and protein quality control in diabetic HFpEF: unraveling mechanisms and therapeutic targets.
Journal: Cardiovascular diabetology
Published: February 19, 2025
SLC4A3-related short QT syndrome assessed in human induced pluripotent stem cell-derived cardiomyocytes: mechanisms of ventricular arrhythmia and sudden cardiac death.
Journal: European heart journal
Published: December 19, 2024
Exploring PKG signaling as a therapeutic avenue for pressure overload, ischemia, and HFpEF.
Journal: Expert opinion on therapeutic targets
Published: September 27, 2024
PDE9A Inhibition Improves Coronary Microvascular Rarefaction and Left Ventricular Diastolic Dysfunction in the ZSF1 Rat Model of HFpEF.
Journal: Microcirculation (New York, N.Y. : 1994)
Published: May 06, 2024
Protein Kinase D Plays a Crucial Role in Maintaining Cardiac Homeostasis by Regulating Post-Translational Modifications of Myofilament Proteins.
Journal: International journal of molecular sciences
Published: January 09, 2024
Sex-specific cardiovascular remodeling leads to a divergent sex-dependent development of heart failure in aged hypertensive rats.
Journal: GeroScience
Published: December 09, 2023
Oxidative stress and inflammation distinctly drive molecular mechanisms of diastolic dysfunction and remodeling in female and male heart failure with preserved ejection fraction rats.
Journal: Frontiers in cardiovascular medicine
Published: February 02, 2023
Ca2+/calmodulin-dependent protein kinase II and protein kinase G oxidation contributes to impaired sarcomeric proteins in hypertrophy model.
Journal: ESC heart failure
Published: March 02, 2022
SARS-CoV-2 infects human cardiomyocytes promoted by inflammation and oxidative stress.
Journal: International journal of cardiology
Published: January 18, 2022
Do they come together? Protein quality control, stress-activated signaling, and "sarcostat" in hypertrophic cardiomyopathy progression.
Journal: International journal of cardiology
Published: October 25, 2021
Last Updated: 09/26/2026